Dexcom (DXCM)

EBITDA Margin

31.38%

TTM · Period ending:

DXCM logo

DXCM EBITDA Margin

Latest reported31.38%
DXCM TTM EBITDA Margin (-236420.13% → 31.38%)
High-resolution chart · PNG

DXCM ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Dexcom EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
31.3753%
30.7022%
29.1399%
27.0688%
24.1629%
23.5077%
23.449%
24.6662%
26.2123%
26.1876%
25.3071%
23.1355%
21.3848%
19.8015%
19.4549%
15.5793%
13.6867%
14.2946%
14.5518%
18.9462%
20.1161%
19.3872%
19.5568%
20.5646%
19.2483%
16.6063%
14.4444%
-5.2398%
-7.13%
-5.6132%
-7.2412%
11.2508%
6.2102%
0.4207%
-2.7418%
-6.0266%
-9.6254%
-11.6116%
-8.5819%
-7.7876%
-13.667%
-11.63%
-11.5423%
-13.2208%
-3.1632%
-4.563%
-5.054%
-7.7229%
-9.3766%
-13.0704%
-13.6875%
-19.8113%
-32.1515%
-40.2596%
-49.1952%
-60.3975%
-60.3966%
-53.7044%
-53.7277%
-56.1506%
-63.2793%
-83.0398%
-106.2347%
-118.3224%
-126.1232%
-150.0294%
-145.2767%
-197.3857%
-268.5787%
-365.1854%
-500.6099%
-664.3308%
-697.8623%
-806.3538%
-936.7625%
-1,092.9425%
-1,293.2489%
-1,486.5006%
-2,114.5454%
-3,550.9466%
-8,222.0175%
-236,420.1286%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.